Alignment Healthcare, INC Form 4 insider transactions

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold shares of common stock to cover tax withholding obligations and pursuant to a pre-arranged 10b5-1 trading plan.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold shares to cover tax withholding obligations related to vested stock.

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold shares of common stock on March 19, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Dawn Maroney, President of Alignment Healthcare, sold shares of common stock on March 18th and 19th, 2025, to cover tax withholding obligations related to vested stock awards.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold shares to cover tax withholding obligations related to vested stock.

Alignment Healthcare's CEO, John Kao, sold shares on March 18th and 19th, 2025, to cover tax withholding obligations related to vested stock.

General Atlantic (ALN HLTH), L.P. reports acquisition of restricted stock units for two directors of Alignment Healthcare, Inc.

General Atlantic and affiliated entities report acquisition of restricted stock units and changes in beneficial ownership of Alignment Healthcare, Inc. common stock.

Director Mark B. McClellan acquired 12,258 restricted stock units of Alignment Healthcare, Inc. on March 13, 2025.

David Hodgson, a director of Alignment Healthcare, Inc., acquired 18,710 restricted stock units, which are held for the benefit of General Atlantic Service Company, L.P., and disclaims beneficial ownership.

Director Nicholas Vorhoff acquired 18,710 restricted stock units in Alignment Healthcare, but disclaims beneficial ownership.

Joseph S. Konowiecki, a director of Alignment Healthcare, acquired 12,258 restricted stock units on March 13, 2025, with vesting contingent on continued service and a deferral of share receipt.

Director Jody Bilney acquired 15,484 shares of Alignment Healthcare through restricted stock units, which vest on the one-year anniversary of the grant date.

Director Yon Jorden acquired 12,258 shares of Alignment Healthcare through restricted stock units, increasing their holdings to 92,734 shares.

Margaret M. McCarthy, a director of Alignment Healthcare, acquired 12,258 restricted stock units on March 13, 2025, which will vest on the one-year anniversary of the grant date.

Jacqueline B. Kosecoff, a director of Alignment Healthcare, acquired 12,258 restricted stock units on March 13, 2025.

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, reports acquisition of shares through restricted stock units and shares granted in lieu of cash settlement.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, reports the acquisition of 39,677 restricted stock units.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, reports acquisition and disposal of common stock and restricted stock units.

Hyong (Ken) Kim, Chief Medical Officer of Alignment Healthcare, reports the acquisition and disposal of company stock and restricted stock units.

Robert Thomas Freeman, CFO of Alignment Healthcare, reports acquiring and disposing of common stock, including restricted stock units and shares held indirectly through a trust.

John Kao, CEO of Alignment Healthcare, reports the acquisition of common stock and adjustments to his beneficial ownership.

Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock at an average price of $15.9896 on March 17, 2025, while also receiving 170,968 shares on March 13, 2025.

COO of Alignment Healthcare, Sebastian Burzacchi, reports acquisition of restricted stock units and disposal of common stock.

Andreas P. Wagner, Chief Human Resources Officer of Alignment Healthcare, reports acquiring 35,109 shares of common stock through restricted stock units and shares granted in lieu of cash settlement.

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold shares of common stock on March 12, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Dawn Maroney, President of Alignment Healthcare, sold shares of common stock on March 12, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Alignment Healthcare's CEO, John Kao, executed multiple sales of common stock, including transactions to cover tax withholding obligations and sales under a pre-arranged 10b5-1 trading plan.